FDA Enforcement Class II Ongoing

FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system.

Recall: Z-2609-2025 · Reported October 1, 2025

Enforcement

Recall Number
Z-2609-2025
Event ID
97286
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Biofire Defense
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
October 1, 2025
Initiation Date
July 10, 2025
Classification Date
September 19, 2025
Address
79 W 4500 S Ste 14, N/A, Salt Lake City, UT, 84107-2663, United States

Description

FilmArray NGDS Warrior Panel NGDS-ASY-0007 is a qualitative, multiplexed, nucleic acid-based in vitro diagnostic test intended for use with the FilmArray 2.0 system.

Reason

FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.

Code Info

UDI-DI: 00851458005136. Lot(Expiration): 324324D(2026-02-19), D241022(2026-01-22), 319524D(2025-11-20), 315424D(2025-10-09), 315224D(2025-10-03), 315324D(2025-10-08)

Distribution

US Nationwide distribution in the states of AL, AZ, UT, CA, TX, DC , VA, FL, MD, OH, HI, NY, KY, LA, MA, MI, MN, MO, NC, NH, RI, NV, TN, IA, WA.

Quantity

130 Kits